A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)

NCT02612558 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Warm Antibody Autoimmune Hemolytic Anemia

Interventions

DRUG: Fostamatinib 150 mg bid

Sponsor

Rigel Pharmaceuticals